remedē System Therapy Study

You may be eligible if

• 1. Moderate to severe central sleep apnea (AHI ≥ 15 events per hour) based on a sleep study scored by a local sleep laboratory. It is strongly recommended that a patient have a diagnostic PSG within 12 months of the expected implant date documenting moderate to severe CSA.
• 2. Age 18 years or older
• 3. Signed Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved informed consent
• 4. In the opinion of the investigator, subject is willing and able to comply with the protocol.
• 5. Not currently enrolled in another investigational study or registry that would directly interfere with the current study, except if the subject is participating in a mandatory government registry, or a purely observational registry with no associated treatments. Each instance should be brought to the attention of the sponsor to determine eligibility.
• 6. In the opinion of the Investigator, life expectancy exceeds one year.
• 7. The subject is not pregnant or planning to become pregnant.